Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing blood vessel growth in asymptomatic carotid stenosis using ultrasound

Official title: Predictive Value of Carotid Lesion Neovascularization Detected by Contrast-enhanced Ultrasound (CEUS) in Patients With Asymptomatic Carotid Stenosis

Run by University Hospital, Basel, Switzerland · NCT01732523 · Data updated 2026-11-12

This study is trying to see if a special ultrasound can help find tiny blood vessels in the neck arteries of people who have narrowing but no symptoms, to better understand the risk of future strokes.

More Carotid Stenosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedOctober 2012
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedApril 3, 2025
Trial IDNCT01732523 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are asymptomatic adults over 18 years with at least 30% carotid stenosis as determined by standard ultrasound.

Probably not a fit

Patients with a history of carotid surgery, severe heart failure, recent myocardial infarction, or significant pulmonary hypertension may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of neovascularization in asymptomatic carotid stenosis by utilizing contrast-enhanced ultrasound (CEUS) imaging techniques. The study aims to identify the microcirculation within the vessel wall and atherosclerotic plaques, which may indicate plaque vulnerability. Participants will receive a CEUS examination after the injection of ultrasound contrast agents to evaluate the presence of vasa vasorum associated with carotid stenosis. The findings could enhance understanding of plaque stability and the risk of future cerebrovascular events.

Why it matters

Potential benefit: If successful, this study could lead to improved risk stratification and management of patients with carotid stenosis, potentially preventing strokes.

How similar studies have gone: While the approach of using CEUS for assessing carotid stenosis is established, the specific focus on neovascularization in asymptomatic patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients age \> 18 years
* Asymptomatic (no history of cerebrovascular event in the corresponding vessel territory) ≥30% carotid stenosis on standard carotid ultrasound

Exclusion Criteria:

* History of previous carotid endarterectomy or carotid stenting.
* Heart failure (HYHA III or IV)
* Myocardial infarction (\<7d)
* Severe pulmonal-arterial hypertension (pulmonal arterial pressure \>90mmHg) based on clinical information (history of pulmonal arterial pressure, dyspnea on exertion New York Heart Association (NYHA) III and NYHA IV)
* pregnancy (pregnancy test in patients of childbearing age: \<50 years and/or less than 2 years after menopause)
* Follow-up is not considered feasible

Where it's running

  • Unversity Hospital Basel, Angiology
    Basel, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Daniel Staub, MD — University Hospital Basle, Angiology
  • Study coordinator: Daniel Staub, MD
  • Email: daniel.staub@usb.ch
  • Phone: +41612655154

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.